Categories: Technology

C-Lingo: Transforming Chinese Language Learning in Vietnam with AI

HONG KONG, May 24, 2026 (GLOBE NEWSWIRE) — As economic and cultural exchanges between Vietnam and China deepen, the demand for high-quality, digital-intelligent Chinese education is surging. On May 23, 2026, Hong Kong-based NSK officially launches its flagship C-Lingo global solution. As a pioneer in autonomous Chinese learning, C-Lingo is committed to breaking geographical boundaries through its proprietary “Connected Learning” architecture, providing learners in Vietnam and across the world with a high-efficiency digital education path.

AI-Powered Evolution in Chinese Education

In Vietnam, Chinese serves both as a catalyst for professional advancement and as a fundamental pillar of personal growth, acting as a bridge to global culture. As Chinese is increasingly integrated into national education systems, the demand for systematic learning is at an all-time high. However, learners often struggle with traditional, static content. C-Lingo solves this by integrating New HSK standards and Happy Chinese, part of the latest major project sponsored by the Center for Language Education and Cooperation under the Ministry of Education of China, into intelligent, interactive experiences, C-Lingo empowers learners worldwide to move beyond simple memorization and achieve real-world mastery.

Connected Learning: A Closed-Loop for Language Acquisition

To translate AI technology into measurable outcomes, C-Lingo pioneered the “Connected Learning” methodology. Anchored by the AIDEO system and a robust knowledge graph, this framework precisely deconstructs curricula. By synergizing personalized AI engines with gamified incentives, it transforms content into sustainable, digital progress paths. Crucially, C-Lingo ensures ubiquitous access—our systems are fully optimized for high-performance offline use, allowing learners to study anytime, anywhere, regardless of network conditions.

This methodology is realized through C-Lingo’s smart hardware, tailored to meet local needs:

AI Chinese Learning Tablet: A core hub integrating the six-pillar cycle of “Teaching, Learning, Practice, Assessment, Evaluation, and Exploration,” offering localized curriculum support and AI-driven personalized efficiency.

Chinese Learning ScanPen: A portable tool for all-scenario offline decoding, helping students seamlessly integrate Chinese into their daily lives and effectively breaking classroom boundaries.

“Beyond Language. To Bigger Worlds.” As a leading partner in the language learning revolution, C-Lingo combines “authoritative content, AI technology, and hardware” to provide practical support for education. We will continue to refine our products, empowering every learner to explore a broader future.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7cca807d-7f26-485d-9de9-e1eee425d750



GlobeNews Wire

Recent Posts

FemiCore (Official Website & Authenticity Notice 2026) Counterfeit Risks and What Consumers Should Know

New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's health supplement market…

3 hours ago

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong Embodied AI Challenge…

3 hours ago

Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000

MONACO, June 12, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after…

3 hours ago

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

5 hours ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

6 hours ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

6 hours ago